Results 21 to 30 of about 52,371 (280)

Clinical significance of LncRNA-MIAT as a non-invasive diagnostic marker of non-Hodgkin's lymphoma associated with occult hepatitis C virus infection [PDF]

African Journal of Gastroenterology and Hepatology, 2023
Aims: the current research aimed to investigate LncRNA-MIAT in patients with non-Hodgkin lymphoma (NHL) and to assess its correlation with clinicopathological features and treatment protocols of NHLs among Egyptian patients with Occult hepatitis C virus (
Nearmeen Rashad, Sameh Soliman, Ahmed Obaya, Abdelmonem Elshamy, Amira El Helaly, Marwa Hussien, Ahmed Gomaa   +6 more
doaj   +1 more source

STATUS ANEMIA TIDAK BERHUBUNGAN DENGAN SUBTIPE DIFFUSE LARGE B-CELL LYMPHOMA

Jurnal Kedokteran dan Kesehatan, 2023
Diffuse large B-cell lymphoma (DLBCL) merupakan neoplasma sel-B sedang atau besar yang pola pertumbuhanya secara difus dengan inti besar. Sekitar 30-40 % kasus limfoma merupakan DLBCL.
Angga Febriyanto, Krisna Murti, Soilia Fertilita   +2 more
doaj  

A bone-based 3D scaffold for investigating DLBCL lymphoma cell interactions within the microenvironment: from tumor biology to therapeutic implications

, 2023
reservedDLBCL is the most common lymphoma and accounts for approximately 30% of all non-Hodgkin lymphomas. DLBCL arises from a mature B cell with characteristics resembling centroblasts or immunoblasts, two distinct types of activated B cells.
GUALTIERO, GIULIA
core  

Clinical outocomes and therapy of polyploid DLBCL and control DLBCL.

, 2018
Clinical outocomes and therapy of polyploid DLBCL and control DLBCL.
Takuto Miyagishima (5088950), Hiroaki Miyoshi (2818363), Junichi Kiyasu (5088947), Masao Seto (73894), Tomohiko Kamimura (287232), Takanori Teshima (2816914), Joji Shimono (5088944), Koji Nagafuji (410643), Koichi Ohshima (230585), Tetsuya Eto (3571922)   +9 more
core   +1 more source

Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma

Клиническая онкогематология, 2017
Background & Aims. Hodgkin’s lymphoma (HL) is still considered one of the most curable oncohematological diseases of lymphoid tissue. 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) combined with multispiral computed tomography (CT ...
Anatolii Anatol’evich Rukavitsyn, S. I. Kurbanov, O. A. Rukavitsyn   +2 more
doaj   +1 more source

Clinical features of polyploid DLBCL and control DLBCL.

, 2018
Clinical features of polyploid DLBCL and control DLBCL.
Takuto Miyagishima (5088950), Hiroaki Miyoshi (2818363), Junichi Kiyasu (5088947), Masao Seto (73894), Tomohiko Kamimura (287232), Takanori Teshima (2816914), Joji Shimono (5088944), Koji Nagafuji (410643), Koichi Ohshima (230585), Tetsuya Eto (3571922)   +9 more
core   +1 more source

Comparison of overall survival between localized nasal/paranasal DLBCL and localized skin DLBCL.

, 2013
Comparison of overall survival between localized nasal/paranasal DLBCL and localized skin DLBCL.
Tadashi Yoshino (283913), Katsuyoshi Takata (283908), Yasuharu Sato (283907), Yorihisa Orita (283912), Hiroko Toda (383873), Naoko Asano (383874)   +5 more
core   +1 more source

Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience

Hematology/Oncology and Stem Cell Therapy, 2018
Surveillance scans after autologous stem cell transplant (auto-HCT) for patients with relapsed/refractory (RR) diffuse large B Cell lymphoma (DLBCL) have no proven survival benefit.
Ghulam Rehman Mohyuddin, Ashley Elizabeth Clark, John Roller, Leyla Shune, Tara Lin, Neil Dunavin, Ajoy Dias, Siddhartha Ganguly, Sunil Abhyankar, Joseph McGuirk, Anurag Singh   +10 more
doaj   +1 more source

Comparison of overall survival between localized nasal/paranasal DLBCL and localized nodal DLBCL.

, 2013
Comparison of overall survival between localized nasal/paranasal DLBCL and localized nodal DLBCL.
Tadashi Yoshino (283913), Katsuyoshi Takata (283908), Yasuharu Sato (283907), Yorihisa Orita (283912), Hiroko Toda (383873), Naoko Asano (383874)   +5 more
core   +1 more source

Investigating the Expression of D-type Cyclins in Diffuse Large B-cell Lymphoma (DLBCL)

, 2023
Diffuse Large B-cell Lymphoma (DLBCL) is a highly aggressive and highly heterogenous cancer which varies dramatically in response to treatment. Attempts to classify DLBCL have identified two distinct subgroups, an Activated B-cell like (ABC-DLBCL) and a ...
Daniel G. Bowden (15906222)
core   +1 more source